Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-DNAJB1 antibody (271-320 aa) (STJ93619) | Login | Anti-DNAJB1 antibody (271-320 aa) (STJ93619) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSP90AA1 antibody (683-732 aa) (STJ93622) | Login | Anti-HSP90AA1 antibody (683-732 aa) (STJ93622) | ||||||||||||||||
|
||||||||||||||||||
Anti-ICAM1 antibody (479-528 aa) (STJ93634) | Login | Anti-ICAM1 antibody (479-528 aa) (STJ93634) | ||||||||||||||||
|
||||||||||||||||||
Anti-IFIT1 antibody (41-90 aa) (STJ93640) | Login | Anti-IFIT1 antibody (41-90 aa) (STJ93640) | ||||||||||||||||
|
||||||||||||||||||
Anti-IGF-IR antibody (1126-1175 aa) (STJ93647) | Login | Anti-IGF-IR antibody (1126-1175 aa) (STJ93647) | ||||||||||||||||
|
||||||||||||||||||
Anti-IGF1R antibody (1131-1180 aa) (STJ93648) | Login | Anti-IGF1R antibody (1131-1180 aa) (STJ93648) | ||||||||||||||||
|
||||||||||||||||||
Anti-IGF-I antibody (100-149 aa) (STJ93653) | Login | Anti-IGF-I antibody (100-149 aa) (STJ93653) | ||||||||||||||||
|
||||||||||||||||||
Anti-ANGPT2 antibody (197-496) (STJ22609) | Login | Anti-ANGPT2 antibody (197-496) (STJ22609) | ||||||||||||||||
|
||||||||||||||||||
Anti-APP antibody (200-300) (STJ22656) | Login | Anti-APP antibody (200-300) (STJ22656) | ||||||||||||||||
|
||||||||||||||||||
Anti-APP antibody (1-100) (STJ22657) | Login | Anti-APP antibody (1-100) (STJ22657) | ||||||||||||||||
|
||||||||||||||||||
Anti-AR antibody (1-100) (STJ22662) | Login | Anti-AR antibody (1-100) (STJ22662) | ||||||||||||||||
|
||||||||||||||||||
Anti-AREG antibody (20-252) (STJ22665) | Login | Anti-AREG antibody (20-252) (STJ22665) | ||||||||||||||||
|
||||||||||||||||||
Anti-ARNT antibody (420-485) (STJ22685) | Login | Anti-ARNT antibody (420-485) (STJ22685) | ||||||||||||||||
|
||||||||||||||||||
Anti-B2M antibody (21-119) (STJ22751) | Login | Anti-B2M antibody (21-119) (STJ22751) | ||||||||||||||||
|
||||||||||||||||||
Anti-FAS antibody (200-335) (STJ23628) | Login | Anti-FAS antibody (200-335) (STJ23628) | ||||||||||||||||
|
||||||||||||||||||
Anti-FASN antibody (2221-2511) (STJ23631) | Login | Anti-FASN antibody (2221-2511) (STJ23631) | ||||||||||||||||
|
||||||||||||||||||
Anti-FASN antibody (2212-2511) (STJ23632) | Login | Anti-FASN antibody (2212-2511) (STJ23632) | ||||||||||||||||
|
||||||||||||||||||
Anti-FCER2 antibody (48-321) (STJ23639) | Login | Anti-FCER2 antibody (48-321) (STJ23639) | ||||||||||||||||
|
||||||||||||||||||
Anti-FCER2 antibody (48-321) (STJ23639) | Login | Anti-FCER2 antibody (48-321) (STJ23639) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF2 antibody (143-288) (STJ23655) | Login | Anti-FGF2 antibody (143-288) (STJ23655) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGFR2 antibody (1-100) (STJ23658) | Login | Anti-FGFR2 antibody (1-100) (STJ23658) | ||||||||||||||||
|
||||||||||||||||||
Anti-VEGFD antibody (20-220) (STJ23665) | Login | Anti-VEGFD antibody (20-220) (STJ23665) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT1 antibody (1100-1180) (STJ23673) | Login | Anti-FLT1 antibody (1100-1180) (STJ23673) | ||||||||||||||||
|
||||||||||||||||||
Anti-FMO2 antibody (210-470) (STJ23677) | Login | Anti-FMO2 antibody (210-470) (STJ23677) | ||||||||||||||||
|
||||||||||||||||||
Anti-FMO2 antibody (210-470) (STJ23677) | Login | Anti-FMO2 antibody (210-470) (STJ23677) | ||||||||||||||||
|